While PHLDA3 is known as a suppressor of neuroendocrine tumorigenicity, its deficiency has been shown to increase islet proliferation, prevent apoptosis, and enhance insulin-releasing functions without leading to tumor formation. This evidence concerns the gene PHLDA3 and neoplasm.